CA
AST

Claro Advisors’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Claro Advisors’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-41
Closed – – 1135
2018
Q4 		$0 Buy
+41
New +$43 ﹤0.01% 1140

Claro Advisors's AST Position: Q1 2019 in Review

Claro Advisors sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 41 shares.

Claro Advisors first reported a position in AST in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

  • Claro Advisors reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
  • Claro Advisors sold 41 Asterias Biotherapeutics Inc. Series A shares in Q1 2019.
  • Claro Advisors first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2018 and held it in 1 quarter.
  • Claro Advisors's Asterias Biotherapeutics Inc. Series A position peaked at $0 in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on Claro Advisors's 13F filing for Q1 2019, filed 10 May 2019.